Game On: Court Ruling on Myriad Patents to Kick off Protracted Legal Battle Over DNA Patentability
March 31, 2010
Game On: Court Ruling on Myriad Patents to Kick off Protracted Legal Battle Over DNA Patentability
A US District Court's ruling that Myriad's BRCA patents are invalid will definitely be appealed in the Federal Circuit, and will probably reach the Supreme Court, according to legal experts.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.